Table 4.
Representative natural products coordinated with Mn2+/3+
| NO | Natural products | Metal ions | Preparation | TME Response | Size | Treatment | Bioimaging | Reference |
|---|---|---|---|---|---|---|---|---|
| 1 | Tannic acid, TA | Mn2+ | Stirring | pH, GSH | 151 ± 24 nm | GT/CT | FI | [141] |
| 2 | Tannic acid, TA | Mn2+ | High temperature heating | pH, GSH | ~ 230 nm | CDT/GT/CT | FI | [142] |
| 3 | Methotrexate, MTX | Mn2+ | Sonication | pH | 93.3 ± 10.3 nm | CT | MRI | [143] |
| 4 | Polydopamine, PDA | Mn2+ | Magnetic stirring | – | 105 nm | CDT/PTT | MRI/PTI /FI | [147] |
| 5 | Hematoporphyrin monomethyl ether, HMME | Mn3+ | Mild sonication | GSH | ~ 100 nm | CT/CDT/PDT | MRI | [144] |
| 6 | Doxorubicin, DOX; chlorin e6, Ce6 | Mn2+ | Sonication | pH | 125 ± 6.1 nm | CT/PDT | MRI | [136] |
| 7 | Carrying DNA | Mn2+ | – | pH | ~ 100 nm | CDT | – | [148] |
| 8 | Cyclic dinucleotide, CDN | Mn2+ | – | pH | 118 ± 41 nm | ICD | – | [138] |
| 9 | Indocyanine green, ICG | Mn2+ | Magnetic stirring | pH | 144.87 ± 2.91 nm | CT/CDT/PTT | FI/MRI | [145] |
| 10 | Beomycin, BLM | Mn2+ | In Vivo self-assembly | GSH | ~ 300 nm | CT | MRI | [146] |
| 11 | Resiquimod R848 | Mn2+ | Stirring | pH | ~ 100 nm | PTT/ICD/CDT | FI/PAI | [140] |
| 12 | Gallic acid, GA | Mn2+ | Magnetic stirring | pH | 164.2 nm | PTT | PTI | [137] |
| 13 | 2-methylimidazole, 2-MI | Mn2+ | Magnetic stirring | pH | ~ 130 nm | ICD | FI | [135] |
| 14 | Banoxantrone; AQ4N | Mn2+ | Magnetic stirring | pH | ~ 100 nm | CT | PAI | [134] |